Travere Therapeutics bobbled around today only ended up 0.75% since yesterday.
Currently TVTX isn't at a clear support/resistance line that seems tradable. But let's also consider momentum! Travere Therapeutics has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the asset has grown 251.39 percent which isn't too bad. It may find some support around the $45.74 price level in the near term.